Related references
Note: Only part of the references are listed.A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and Y-90-loaded glass microsphere selective internal radiation therapy
Vincent Manceau et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer
Hugo Levillain et al.
EJNMMI RESEARCH (2018)
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet S. Wasan et al.
LANCET ONCOLOGY (2017)
Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study
Alessandro Cucchetti et al.
LIVER INTERNATIONAL (2017)
Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis
Kathy P. Willowson et al.
EJNMMI RESEARCH (2017)
Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE
Brian M. Currie et al.
SEMINARS IN INTERVENTIONAL RADIOLOGY (2017)
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
Erwin Woff et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases
Andor F. van den Hoven et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method-A Less than Perfect Model
Oliver S. Grosser et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer
Susan J. Dutton et al.
BMC CANCER (2014)
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study
Peter Gibbs et al.
BMC CANCER (2014)
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective
Marta Cremonesi et al.
FRONTIERS IN ONCOLOGY (2014)
Yttrium-90 Radioembolization for Unresectable Standard-chemorefractory Intrahepatic Cholangiocarcinoma: Survival, Efficacy, and Safety Study
Shoaib Rafi et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
Ralf-T. Hoffmann et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Image-Guided Personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization
Yung Hsiang Kao et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
Alexander R. Haug et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Clinical Feasibility of Fast 3-Dimensional Dosimetry of the Liver for Treatment Planning of Hepatocellular Carcinoma with 90Y-Microspheres
Arnaud Dieudonne et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma
Armin Thelen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option
Akshat Saxena et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X. Zhu et al.
LANCET ONCOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study
Jongha Park et al.
GUT AND LIVER (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres
Patrick Flamen et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
S. A. Khan et al.
HPB (2008)
Surgical management of intrahepatic cholangiocarcinoma - A population-based study
Jensen C. C. Tan et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Share Paper
